| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MEDIVATION INC | 4,397,838 | 212,591,000 | 78.82% | ||
| 2 | AMPIO PHARMACEUTICALS INC | 3,388,322 | 11,859,000 | 4.40% | ||
| 3 | SYNTHETIC BIOLOGICS INC | 3,734,149 | 8,551,000 | 3.17% | ||
| 4 | ALCOBRA LTD | 1,115,315 | 7,004,000 | 2.60% | ||
| 5 | CEMPRA INC | 180,800 | 5,628,000 | 2.09% | ||
| 6 | ABEONA THERAPEUTICS INC | 1,359,767 | 4,569,000 | 1.69% | ||
| 7 | CORBUS PHARMACEUTICALS HLDGS COM | 2,563,925 | 4,230,000 | 1.57% | ||
| 8 | NEWLINK GENETICS CORP | 102,437 | 3,728,000 | 1.38% | ||
| 9 | ADVAXIS INC COM NEW | 275,000 | 2,767,000 | 1.03% | ||
| 10 | Vascular Biologics LTD | 333,332 | 1,753,000 | 0.65% | ||
| 11 | BIOBLAST PHARMA LTD | 338,110 | 1,312,000 | 0.49% | ||
| 12 | OHR PHARMACEUTICAL INC | 205,000 | 1,259,000 | 0.47% | ||
| 13 | KERYX BIOPHARMACEUTICALS INCORPORATED | 200,000 | 1,010,000 | 0.37% | ||
| 14 | ALDEYRA THERAPEUTICS INC | 135,800 | 921,000 | 0.34% | ||
| 15 | AXIS CAPITAL HOLDING | 112,500 | 798,000 | 0.30% | ||
| 16 | Caladrius Biosciences Inc | 555,781 | 600,000 | 0.22% | ||
| 17 | Galmed Pharmaceuticals Ltd | 65,000 | 495,000 | 0.18% | ||
| 18 | CHAMPIONS ONCOLOGY INC | 111,111 | 397,000 | 0.15% | ||
| 19 | Evoke Pharma Inc | 55,660 | 184,000 | 0.07% | ||
| 20 | Zosano Pharma Corp | 18,600 | 42,000 | 0.02% | ||
| 21 | Aptose Biosciences Inc Com New | 11,933 | 31,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-083000, filed 2016.02.17).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
